Parteek Prasher

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 67

Top Topics

Helicobacter Pylori

Top Venues

Future medicinal chemistry

Drug development research

Therapeutic delivery

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Shraddha Chugh, Mousmee Sharma, Garima Chandrasen, Harish Mudila, Parteek Prasher
Synthesis and release studies on amylose-based ester prodrugs of fenamic acid NSAIDs. Therapeutic delivery (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry (2024)
Shraddha Chugh, Mousmee Sharma, Harish Mudila, Parteek Prasher
Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs. Therapeutic delivery (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry 16 (8) (2024)
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
The contemplation of amylose for the delivery of ulcerogenic nonsteroidal anti-inflammatory drugs. Future medicinal chemistry (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Parteek Prasher, Mousmee Sharma
Starch-based "smart" nanomicelles: Potential delivery systems for doxorubicin. Drug development research 85 (6) (2024)
Shraddha Chugh, Mousmee Sharma, Harish Mudila, Parteek Prasher
Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs. Therapeutic delivery (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry (2024)
Shraddha Chugh, Mousmee Sharma, Harish Mudila, Parteek Prasher
Synthesis and evaluation of amylose-mefenamic acid conjugates as colon-targeting prodrugs. Therapeutic delivery (2024)
Parteek Prasher, Mousmee Sharma
ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery. Future medicinal chemistry 16 (9) (2024)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Parteek Prasher, Mousmee Sharma
Hybridization of antimicrobial oxazolidinones with commercial drugs: A fight against the "superbugs". Drug development research (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Tanisqa Mall, Mousmee Sharma
Cyclic carbamates in medicine: A clinical perspective. Drug development research (2023)
Parteek Prasher, Tanisqa Mall, Mousmee Sharma
Synthesis and biological profile of benzoxazolone derivatives. Archiv der Pharmazie (2023)
Parteek Prasher, Mousmee Sharma
Dialdehyde starch nanoparticles: an emerging material for anticancer drug delivery. Nanomedicine (London, England) (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Rabab Fatima, Mousmee Sharma, Akash Dhiman, Anshika Arora, Harish Mudila, Parteek Prasher
Targeted delivery of fenamates with aminated starch. Therapeutic delivery (2023)
Parteek Prasher, Mousmee Sharma
Potential strategies for the management of adenocarcinoma: a perspective. Future medicinal chemistry 15 (2) (2023)
Parteek Prasher, Mousmee Sharma
Layered double hydroxide nanocarriers: potential delivery systems for mefenamic acid. Nanomedicine (London, England) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry 15 (6) (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry (2023)
Parteek Prasher, Mousmee Sharma
Management of adenocarcinoma with honokiol: progress so far and the way forward. Future medicinal chemistry (2023)
Tanisqa Mall, Mousmee Sharma, Parteek Prasher
Mucin glycosylation: a potential target for prostate cancer management. Future medicinal chemistry (2023)
Juman Mohammed Rasmi Alamil, Keshav Raj Paudel, Yinghan Chan, Dikaia Xenaki, Jithendra Panneerselvam, Dinesh Kumar Chellapan, Monica Gulati, Niraj Kumar Jha, Deepak Kumar, Parteek Prasher, Gaurav Gupta, Raniya Malik, Brian Gregory George Oliver, Philip Michael Hansbro, Kamal Dua, Dinesh Kumar Chellappan
Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases. Molecules (Basel, Switzerland) 27 (9) (2022)
Parteek Prasher, Rabab Fatima, Mousmee Sharma
Cationic polysaccharides: emerging drug delivery vehicle across the physiological mucus barrier. Future medicinal chemistry 14 (8) (2022)
Poonam Negi, Surbhi Gautam, Aditi Sharma, Charul Rathore, Lalit Sharma, Navneet Upadhyay, Murtaza M Tambuwala, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Parteek Prasher, Kamal Dua, Shweta Agarwal, Uma Ranjan Lal
Gastric ulcer healing by chebulinic acid solid dispersion-loaded gastroretentive raft systems: preclinical evidence. Therapeutic delivery 13 (2) (2022)
Parteek Prasher, Mousmee Sharma, Manav Sharma, Devendra Singh Rawat
C3 regioselectivity: a major constraint in the drug development with imidazo[1,2-<i>a</i>]pyridines. Future medicinal chemistry 14 (21) (2022)
Parteek Prasher, Mousmee Sharma
Benzimidazole-carbamate anthelmintics: Perspective candidates for the anticancer drug development. Drug development research 83 (2) (2022)
Parteek Prasher, Mousmee Sharma
Targeting mucin hypersecretion in COVID-19 therapy. Future medicinal chemistry 14 (10) (2022)
Daljeet Singh Dhanjal, Parvarish Sharma, Meenu Mehta, Murtaza M Tambuwala, Parteek Prasher, Keshav Raj Paudel, Gang Liu, Shakti Dhar Shukla, Philip Michael Hansbro, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Satija
Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases. Future medicinal chemistry 14 (4) (2022)
Mousmee Sharma, Parteek Prasher
Selected heterocycles for the development of pyrophosphate mimics. Future medicinal chemistry 14 (17) (2022)
Parteek Prasher, Mousmee Sharma, Sachin Kumar Singh, Monica Gulati, Vandana Patravale, Brian G Oliver, Kamal Dua
Mucoadhesive particles: an emerging toolkit for advanced respiratory drug delivery. Nanomedicine (London, England) 17 (12) (2022)
Parteek Prasher, Mousmee Sharma, Dinesh Kumar Chellappan, Gaurav Gupta, Niraj Kumar Jha, Sachin Kumar Singh, Ronan MacLoughlin, Terezinha J A Pinto, Raimar Löbenberg, Kamal Dua
Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future medicinal chemistry 13 (13) (2021)
Parteek Prasher, Mousmee Sharma
Medicinal chemistry of anthranilic acid derivatives: A mini review. Drug development research 82 (7) (2021)
Seyed H Shahcheraghi, Jamshid Ayatollahi, Alaa A A Aljabali, Madhur D Shastri, Shakti Dhar Shukla, Dinesh Kumar Chellappan, Niraj Kumar Jha, Krishnan Anand, Naresh K Katari, Meenu Mehta, Saurabh Satija, Harish Dureja, Vijay Mishra, Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Nitin Charbe, Parteek Prasher, Kamal Dua, Marzieh Lotfi, Hamid A Bakshi, Murtaza M Tambuwala
An overview of vaccine development for COVID-19. Therapeutic delivery 12 (3) (2021)
Keshav Raj Paudel, Saurav Kumar Jha, Venkata Sita Rama Raju Allam, Parteek Prasher, Piyush Kumar Gupta, Rahul Bhattacharjee, Niraj Kumar Jha, Sukriti Vishwas, Sachin K Singh, Jesus Shrestha, Mohammad Imran, Nisha Panth, Dinesh Kumar Chellappan, Majid Ebrahimi Warkiani, Philip Michael Hansbro, Kamal Dua
Recent Advances in Chronotherapy Targeting Respiratory Diseases. Pharmaceutics 13 (12) (2021)
Dinesh Kumar Chellappan, Waleed Hassan Al-Malki, Imran Kazmi, Thangavelu Lakshmi, Piyush Kumar Gupta, Niraj Kumar Jha, Parteek Prasher, Dinesh Kumar Chellapan, Kamal Dua
The role of HGF/MET in liver cancer. Future medicinal chemistry 13 (21) (2021)
Parteek Prasher, Mousmee Sharma
Mucoadhesive nanoformulations and their potential for combating COVID-19. Nanomedicine (London, England) 16 (28) (2021)
Parteek Prasher, Mousmee Sharma, Ravi Gunupuru
Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy. Drug development research 82 (4) (2021)
Yinghan Chan, Parteek Prasher, Raimar Löbenberg, Dinesh Kumar Chellappan, Dinesh Kumar Chellapan, Brian Gregory George Oliver, Dinesh Kumar Chellappan, Kamal Dua
Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseases. Nanomedicine (London, England) 16 (10) (2021)
Parteek Prasher, Mousmee Sharma, Peter Richard Wich, Niraj Kumar Jha, Dinesh Kumar Chellapan, Dinesh Kumar Chellappan, Kamal Dua
Can dextran-based nanoparticles mitigate inflammatory lung diseases? Future medicinal chemistry 13 (23) (2021)
Parteek Prasher, Mousmee Sharma
Medicinal chemistry of pyrophosphate mimics: A mini review. Drug development research (2021)
Rabab Fatima, Mousmee Sharma, Parteek Prasher
Targeted delivery of flufenamic acid by V-amylose. Therapeutic delivery 12 (8) (2021)
Parteek Prasher, Rabab Fatima, Mousmee Sharma
Resistant starch: ideal candidate for the enteric coating of NSAIDs? Future medicinal chemistry 13 (17) (2021)
Parteek Prasher, Rabab Fatima, Mousmee Sharma
Therapeutic delivery with V-amylose. Drug development research 82 (6) (2021)
Parteek Prasher, Mousmee Sharma
Nanotechnology-based self-sterilizing surfaces and their potential in combating COVID-19. Nanomedicine (London, England) 16 (14) (2021)
Hamid A Bakshi, Mazhar Salim Al Zoubi, Faruck L Hakkim, Alaa A A Aljabali, Firas A Rabi, Amin A Hafiz, Khalid M Al-Batanyeh, Bahaa Al-Trad, Prawej Ansari, Mohamed M Nasef, Nitin B Charbe, Saurabh Satija, Meenu Mehta, Vijay Mishra, Dinesh Kumar Chellappan, Salem Abobaker, Poonam Negi, Ibrahim M Azzouz, Ashref Ali K Dardouri, Harish Dureja, Parteek Prasher, Dinesh Kumar Chellappan, Kamal Dua, Mateus Webba Da Silva, Mohamed El Tanani, Paul A McCarron, Murtaza M Tambuwala
Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative Damage. Nutrients 12 (6) (2020)
Mousmee Sharma, Parteek Prasher, Meenu Mehta, Flavia C Zacconi, Yogendra Singh, Deepak N Kapoor, Harish Dureja, Dinesh M Pardhi, Murtaza M Tambuwala, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Satija
Probing 3CL protease: Rationally designed chemical moieties for COVID-19. Drug development research (2020)
Parteek Prasher, Mousmee Sharma
N-acetylgalactosaminyltransferase: a potential target for colorectal adenocarcinoma. Future medicinal chemistry 12 (17) (2020)
Parteek Prasher, Mousmee Sharma, Alaa A A Aljabali, Dinesh Kumar Chellappan, Poonam Negi, Deepak N Kapoor, Inderbir Singh, Flavia C Zacconi, Terezinha de Jesus Andreoli Pinto, Mateus Webba da Silva, Hamid A Bakshi, Dinesh Kumar Chellappan, Murtaza M Tambuwala, Kamal Dua
Hybrid molecules based on 1,3,5-triazine as potential therapeutics: A focused review. Drug development research 81 (7) (2020)
Parteek Prasher, Mousmee Sharma
Targeting N-acetylgalactosaminyltransferase for anticancer therapy. Drug development research 82 (1) (2020)
Parteek Prasher, Mousmee Sharma, Samarth Pratap Singh
Drug encapsulating polysaccharide-loaded metal nanoparticles: A perspective drug delivery system. Drug development research 82 (2) (2020)
Parteek Prasher, Mousmee Sharma
"Azole" as privileged heterocycle for targeting the inducible cyclooxygenase enzyme. Drug development research 82 (2) (2020)
Saurabh Satija, Meenu Mehta, Mousmee Sharma, Parteek Prasher, Dinesh Kumar Chellappan, Dinesh Kumar Chellappan, Kamal Dua
Vesicular drug delivery systems as theranostics in COVID-19. Future medicinal chemistry 12 (18) (2020)
Alaa A A Aljabali, Hamid A Bakshi, Faruck L Hakkim, Yusuf A Haggag, Khalid M Al-Batanyeh, Mazhar Salim Al Zoubi, Bahaa Al-Trad, Mohamed M Nasef, Saurabh Satija, Meenu Mehta, Kavita Pabreja, Vijay Mishra, Mohammed Khan, Salem Abobaker, Ibrahim M Azzouz, Harish Dureja, Ritesh M Pabari, Ashref Ali K Dardouri, Prashant Kesharwani, Gaurav Gupta, Shakti Dhar Shukla, Parteek Prasher, Nitin B Charbe, Poonam Negi, Deepak N Kapoor, Dinesh Kumar Chellappan, Mateus Webba Da Silva, Paul Thompson, Kamal Dua, Paul A McCarron, Murtaza M Tambuwala
Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113. Cancers 12 (12) (2020)
Parteek Prasher, Mousmee Sharma, Samarth P Singh, Devendra S Rawat
Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review. Drug development research 82 (3) (2020)
Parteek Prasher, Mousmee Sharma
Tailored therapeutics based on 1,2,3-1H-triazoles: a mini review. MedChemComm 10 (8) (2019)
Mousmee Sharma, Parteek Prasher
An epigrammatic status of the 'azole'-based antimalarial drugs. RSC medicinal chemistry 11 (2) (2019)